With an aim to enhance its global presence and deliver high-quality medicines to a broader market, HOF Pharmaceuticals, the Ahmedabad based, fast-growing pharmaceuticals company, has unveiled ambitious growth plans.
In just two years, HOF Pharmaceuticals has established itself as a premier manufacturer and exporter of tablets, capsules, and oral liquids. The company’s state-of-the-art, export-oriented plant at Sanand in Ahmedabad meets stringent international standards. and positions it perfectly serves to countries with rigorous drug regulatory environments.
“Currently we are exporting to 12 countries across Latin America, Africa, and Southeast Asia. With Twenty more specialty products in pipeline, which will augment HOF’s export performance, we are now aiming to double our reach to 25 countries within the next year” commented Pravin Patel, Chairman, HOF Pharmaceuticals.
“Towards this end, we are gearing up our Quality Management Systems (QMS) and formulation development initiatives towards regulated markets. This should unlock value for us in the next few years’, added Pravin Patel.
HOF Pharmaceuticals' product portfolio is extensive and diverse, comprising over 150 products across various therapeutic categories. These include treatments for diabetes, cardiovascular, central nervous system disorders, immunosuppressant, anticoagulants, anti-anemics, gastric medications, muscular dystrophy treatments, and therapies for hemochromatosis.
